EVENT BIO

SEE BREAKDOWN OF ALL YOU NEED TO KNOW ABOUT OUR SUMMIT

The importance of medical affairs has shifted from a supporting function to a central, strategic one over the past few years. As a bridge between medical and commercial, medical affairs is uniquely placed to work closely with all third parties and restore trust in today’s healthcare environment. That’s why follow-upping on the updates and transformations of medical affairs is a must.
Join us at the 5th Annual Global Medical Affairs Summit to gain valuable insights and fresh perspectives on the current state and future trends of medical affairs. At this two-day business meeting, you will hear from the leading pharma companies internationally that have managed the effectiveness and outstanding performance of their medical affairs teams.
During our interactive conference, you will benefit from remarkable networking opportunities with senior-level decision-makers, as the number of seats is limited. It is the right place to discuss your ideas with peers and establish many business contacts. Do not wait and get yourself a seat at our event!

HOTTEST TOPICS THAT WILL BE DISCUSSED AT THIS ANNUAL

  • Shifting from a brand focus to a patient value focus: How to rebuild trust between pharmaceutical companies and patients?
  • How to break through the performance by fostering the right culture for individuals and teams
  • Improving the performance of medical affairs by implementing virtual reality
  • Critical components to achieving excellence in an omnichannel approach
  • Omnichannel strategy: Building trust and brand loyalty to engage healthcare professionals
  • How can RWE help medical affairs professionals?
  • The art of medical science liaising – Nurture the next MSL generation

WHO WILL YOU MEET

Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from the pharmaceutical industry  involved in:

  • Medical Science Liaisons (MSL)
  • Medical Information
  • Scientific Affairs
  • Real World Evidence
  • Commercial Excellence
  • Market Access
  • KOL/Thought Leader Relations/Engagement
  • Clinical Affairs
  • Medical Review
  • Health Economics and Outcomes Research/HEOR
  • Product Launch
  • Patient Outcome
  • Patient Centricity
  • Digital Medical
  • Scientific Engagement
  • Scientific Partnerships
  • Commercial Operations
  • External Affairs
  • Medical Affairs Operations
  • Medical Strategy
  • Portfolio Planning
  • Launch Management
  • Medical/Scientific/Patient Communications
  • Medical Affairs
  • MA Excellence
  • Medical Education